Prasad Arvind Thakurdesai1, Pallavi Onkar Deshpande1*, Rohini Revansiddappa Pujari2, Shailesh Anil Gumaste3 and Mukul Prabhakar Pore3
1Department of Scientific Affairs, Indus Biotech Limited, Rahul Residency, Off Salunke Vihar Road, Kondhwa, Pune, India.
2Department of Pharmacology, School of Pharmacy, Dr. Vishwanath Karad MIT World Peace University, Kothrud, Pune, India
3INTOX Private Limited., Pune, Maharashtra, India.
Corresponding Author E-mail: pallavi@indusbiotech.com
Fenugreek seed-based ingredients showed potential health benefits towards female-specific conditions. The present work is aimed to assess the prenatal oral toxicity of fibers and protein rich defatted fenugreek seed flakes (Fenuflakes™). The acute oral toxicity and dose range-finding studies in non-pregnant and pregnant rats were conducted before the main study. The selected doses of Fenuflakes (500, 1000, and 2000 mg/kg) were orally gavaged to rats daily from day 0 to day 19 (one day before the expected day of parturition) post-conception with the concurrent vehicle control (VC) group. On the 20th day of gestation, the maternal and embryo-fetal toxicity parameters were recorded after the cesarean sections of dams. Results: Fenuflakes in tested doses exposure did not show significant toxicological changes in maternal (body weights, food intake, anogenital distance, or clinical observations) and embryo-fetal evaluations (number of corpora lutea, resorptions, and implantations, or fetus weights, sex ratio or incidence of anomalies) compared with VC. Conclusion: Oral prenatal exposure to Fenuflakes was found safe with no significant maternal and embryo-fetal toxicities. The "No Observed Adverse Effect Level” (NOAEL) of Fenuflakes (> 2000 mg/kg/day) can be used for risk assessment before human consumption in pregnant female population.
Defatted fenugreek seed flakes; OECD No. 414; Prenatal Developmental toxicity; Reproductive system